Skip to main content

Ovary

Funded projects, calls, countries and funding organisations related to this cancer type.

7
Projects
6
Calls
12
Countries
13
Funders

Funded Projects

7
TRANSCAN-3 JTC 2024

ioAVATAR

Immune oncology Drug Discovery & Decision - Advanced ex Vivo Approach To Accelerate Response prediction for combined therapies in ovarian cancer

University Medical Centre Hamburg-Eppendorf · DE
TRANSCAN-3 JTC 2021

CHRYSALIS

Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis

TRANSCAN-2 JTC 2017

ROCSANbio

Anti-PD1 and Niraparib (PARPi) combination therapy in gynae carcinosarcoma: Identification of response-predictive biomarkers and resistance mechanisms

FR
TRANSCAN-2 JTC 2016

BioEndoCar

Biomarkers for diagnosis and prognosis of endometrial carcinoma

University of Ljubljana, Faculty of Medicine · SI
TRANSCAN-2 JTC 2014

PROMETOV

Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.

German Cancer Research Center, DKFZ, Heidelberg Germany / Brain Cancer Metabolism · DE
TRANSCAN-2 JTC 2014

TH4RESPONS

Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response

Charité University Hospital Berlin / Institute of Pathology · DE
TRANSCAN-1 JTC 2011

ImPECT

Immune Cells as Predictors for Early Diagnosis and Chemotherapy Toxicity in Ovarian Cancer

Medical University of Vienna · AT

Joint Transnational Calls

Countries represented

DE · 7 FR · 4 IT · 3 EE · 2 ES · 2 NL · 2 SI · 2 TR · 2 AT · 1 CA · 1 IL · 1 PL · 1

Funding organisations